Additionally, it addresses the FDA’s communications with the applicant, the retention of documents that assist the SE report, confidentiality of the SE report, how an applicant can amend or withdraw an SE report, how an applicant may well transfer possession of an SE report to a different applicant and electronic submission on the SE report and a